Valanx

Investment date: May 2020 | Biotechnology
 
 
Valanx

VALANX develops new approaches towards bioconjugation. The resulting products, bioconjugates, are applied to build particularly specific medical drugs, special diagnostics or biosensors. VALANX delivers specific links that react fast and are low-cost for the production of directed and specific bioconjugates. VALANX´ revolutionary technology promises to enable the adoption of bioconjugates as a tool for entirely new applications in industry.

 

Job offers at Valanx

Job-Title Department Branch Date
R&D Bio Technology 29.05.20
Business Development Bio Technology 29.05.20